Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza.

Madan A, Chen S, Yates P, Washburn ML, Roberts G, Peat AJ, Tao Y, Parry MF, Barnum O, McClain MT, Roy-Ghanta S.

Open Forum Infect Dis. 2019 Apr 3;6(4):ofz163. doi: 10.1093/ofid/ofz163. eCollection 2019 Apr.

2.

Comparative assessment of DNA methylation patterns between reduced representation bisulfite sequencing and Sequenom EpiTyper methylation analysis.

Chatterjee A, Macaulay EC, Ahn A, Ludgate JL, Stockwell PA, Weeks RJ, Parry MF, Foster TJ, Knarston IM, Eccles MR, Morison IM.

Epigenomics. 2017 Jun;9(6):823-832. doi: 10.2217/epi-2016-0176. Epub 2017 May 19.

3.

scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups.

Chatterjee A, Stockwell PA, Rodger EJ, Parry MF, Eccles MR.

Epigenomics. 2016 Oct;8(10):1315-1330. Epub 2016 Sep 14.

4.

Placental Hypomethylation Is More Pronounced in Genomic Loci Devoid of Retroelements.

Chatterjee A, Macaulay EC, Rodger EJ, Stockwell PA, Parry MF, Roberts HE, Slatter TL, Hung NA, Devenish CJ, Morison IM.

G3 (Bethesda). 2016 Jul 7;6(7):1911-21. doi: 10.1534/g3.116.030379.

5.

Genome-wide DNA methylation map of human neutrophils reveals widespread inter-individual epigenetic variation.

Chatterjee A, Stockwell PA, Rodger EJ, Duncan EJ, Parry MF, Weeks RJ, Morison IM.

Sci Rep. 2015 Nov 27;5:17328. doi: 10.1038/srep17328.

6.

Successful reduction in catheter-associated urinary tract infections: focus on nurse-directed catheter removal.

Parry MF, Grant B, Sestovic M.

Am J Infect Control. 2013 Dec;41(12):1178-81. doi: 10.1016/j.ajic.2013.03.296. Epub 2013 Jun 13.

PMID:
23768439
7.
8.

Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission.

Carling PC, Parry MF, Bruno-Murtha LA, Dick B.

Crit Care Med. 2010 Apr;38(4):1054-9. doi: 10.1097/CCM.0b013e3181cdf705.

PMID:
20081531
9.

Relationship of influenza vaccination declination statements and influenza vaccination rates for healthcare workers in 22 US hospitals.

Polgreen PM, Septimus EJ, Parry MF, Beekmann SE, Cavanaugh JE, Srinivasan A, Talbot TR.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):675-7. doi: 10.1086/588590.

PMID:
18564904
10.

The impact of hospital practice on central venous catheter associated bloodstream infection rates at the patient and unit level: a multicenter study.

Kritchevsky SB, Braun BI, Kusek L, Wong ES, Solomon SL, Parry MF, Richards CL, Simmons B; Evaluation of Processes and Indicators in Infection Control (EPIC) Study Group.

Am J Med Qual. 2008 Jan-Feb;23(1):24-38. doi: 10.1177/1062860607310918.

PMID:
18187588
11.

Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals .

Carling PC, Parry MF, Von Beheren SM; Healthcare Environmental Hygiene Study Group.

Infect Control Hosp Epidemiol. 2008 Jan;29(1):1-7. doi: 10.1086/524329.

PMID:
18171180
12.

Impact of an Adherence Program on the Health and Outlook of HIV-Infected Patients Failing Antiretroviral Therapy.

Parry MF, Wright P, Stewart J, McLeod GX, Tucker J, Weinberg AR.

J Int Assoc Physicians AIDS Care (Chic). 2005 Jul;4(3):59-65.

PMID:
16867973
13.

Influenza vaccination: a collaborative effort to improve the health of the community.

Parry MF, Grant B, Iton A, Parry PD, Baranowsky D.

Infect Control Hosp Epidemiol. 2004 Nov;25(11):929-32.

PMID:
15566026
14.

Collaborative management of HIV infection in the community: an effort to improve the quality of HIV care.

Parry MF, Stewart J, Wright P, McLeod GX.

AIDS Care. 2004 Aug;16(6):690-9.

PMID:
15370058
15.

Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.

Parry MF, Grant B, Yukna M, Adler-Klein D, McLeod GX, Taddonio R, Rosenstein C.

Clin Infect Dis. 2001 Feb 1;32(3):352-7. Epub 2001 Jan 24.

PMID:
11170941
16.

HIV care in the community: creation of a flowchart to assist in coordinating patient care and data management. Stamford HIV/AIDS Care Community Needs Team.

Parry MF, Israel SP, Coq R, Taliercio R, McElhatton S.

AIDS. 1997 Jun;11(7):933-4. No abstract available.

PMID:
9189223
17.

The new era of hospital epidemiology: what you need to succeed.

Simmons BP, Parry MF, Williams M, Weinstein RA.

Clin Infect Dis. 1996 Mar;22(3):550-3. Review.

PMID:
8852976
18.

Appropriateness of serologic tests and parenteral antibiotic therapy for patients with presumed Lyme disease.

Gerber MA, Bieluch V, Levitz RE, Parry MF, Sabetta J, Schleiter G.

Conn Med. 1995 Apr;59(4):195-6. Review. No abstract available.

PMID:
7606906
19.

False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children.

Levine D, Tilton RC, Parry MF, Klenk R, Morelli A, Hofreuter N.

Pediatrics. 1994 Dec;94(6 Pt 1):892-4.

PMID:
7971007
20.

Pharmacology and clinical uses of quinolone antibiotics.

Parry MF.

Indian J Med Sci. 1990 Dec;44(12):351-4. Review. No abstract available.

PMID:
2093086
21.

Aztreonam susceptibility testing. A retrospective analysis.

Parry MF.

Am J Med. 1990 Mar 23;88(3C):7S-11S; discussion 38S-42S.

PMID:
2180295
22.

Quinolone resistance. Susceptibility data from a 300-bed community hospital.

Parry MF, Panzer KB, Yukna ME.

Am J Med. 1989 Nov 30;87(5A):12S-16S.

PMID:
2511756
23.

Epidemiology and mechanisms of antimicrobial resistance.

Parry MF.

Am J Infect Control. 1989 Oct;17(5):286-94. Review.

PMID:
2683887
24.

Hepatobiliary kinetics and excretion of ciprofloxacin.

Parry MF, Smego DA, Digiovanni MA.

Antimicrob Agents Chemother. 1988 Jul;32(7):982-5.

25.

The radiologic manifestations of Legionella pneumonia.

Muder RR, Yu VL, Parry MF.

Semin Respir Infect. 1987 Dec;2(4):242-54. Review.

PMID:
3328894
26.

The penicillins.

Parry MF.

Med Clin North Am. 1987 Nov;71(6):1093-112. Review.

PMID:
3320613
27.

Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates.

Ellner PD, Fink DJ, Neu HC, Parry MF.

J Clin Microbiol. 1987 Sep;25(9):1668-74.

28.

Pseudomembranous colitis caused by topical clindamycin phosphate.

Parry MF, Rha CK.

Arch Dermatol. 1986 May;122(5):583-4.

PMID:
2939805
29.

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.

Scully BE, Neu HC, Parry MF, Mandell W.

Lancet. 1986 Apr 12;1(8485):819-22.

PMID:
2870313
30.

Waterborne Legionella bozemanii and nosocomial pneumonia in immunosuppressed patients.

Parry MF, Stampleman L, Hutchinson JH, Folta D, Steinberg MG, Krasnogor LJ.

Ann Intern Med. 1985 Aug;103(2):205-10.

PMID:
4014902
31.

The safety and tolerance of azlocillin.

Parry MF.

Arzneimittelforschung. 1985;35(8):1292-4.

PMID:
4074446
32.

Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics.

Parry MF, Jacobs B, Scully B, Neu HC.

Diagn Microbiol Infect Dis. 1984 Jun;2(3):229-31.

PMID:
6744802
33.

Toxic and adverse reactions encountered with new beta-lactam antibiotics.

Parry MF.

Bull N Y Acad Med. 1984 May;60(4):358-68. No abstract available.

34.
35.

The tolerance and safety of azlocillin.

Parry MF.

J Antimicrob Chemother. 1983 May;11 Suppl B:223-8.

PMID:
6619031
36.

The in-vitro activity of azlocillin: a community hospital study of 1900 clinical isolates.

Parry MF.

J Antimicrob Chemother. 1983 May;11 Suppl B:15-20.

PMID:
6619025
37.

Umbilical stump cultures detect IC violations.

Parry MF.

Hosp Infect Control. 1983 May;10(5):59-60. No abstract available.

PMID:
10260090
38.

Mycotic aneurysm of the abdominal aorta: successful management of Campylobacter fetus aortitis.

Blabey RG Jr, Parry MF, Bull SM, Weed CB.

Conn Med. 1983 Mar;47(3):129-30. No abstract available.

PMID:
6851545
39.

Aspergillus empyema.

Parry MF, Coughlin FR, Zambetti FX.

Chest. 1982 Jun;81(6):768-70.

PMID:
7075317
40.

Pseudomonas aeruginosa skin infections in persons using a whirlpool in Vermont.

Vogt R, LaRue D, Parry MF, Brokopp CD, Klaucke D, Allen J.

J Clin Microbiol. 1982 Apr;15(4):571-4.

41.

The safety and tolerance of mezlocillin.

Parry MF, Neu HC.

J Antimicrob Chemother. 1982 Jan;9 Suppl A:273-80. No abstract available.

PMID:
6210679
42.

Myeloperoxidase deficiency: prevalence and clinical significance.

Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ.

Ann Intern Med. 1981 Sep;95(3):293-301.

PMID:
6267975
43.

Ecthyma-like skin lesions caused by Staphylococcus aureus.

Turnbull D, Parry MF.

Arch Intern Med. 1981 Apr;141(5):689. No abstract available.

PMID:
7224754
44.

Cephalosporin cost reduction.

Martucci HJ, Parry MF.

Hosp Formul. 1981 Apr;16(4):396-8, 403. No abstract available.

PMID:
10250718
45.

Gram-negative sepsis in neonates: a nursery outbreak due to hand carriage of Citrobacter diversus.

Parry MF, Hutchinson JH, Brown NA, Wu CH, Estreller L.

Pediatrics. 1980 Jun;65(6):1105-9.

PMID:
7375234
46.

Acute interstitial nephritis associated with carbenicillin therapy.

Appel GB, Woda BA, Neu HC, Parry MF, Silva F, Pirani CL.

Arch Intern Med. 1978 Aug;138(8):1265-7.

PMID:
677983
47.

Cefoxitin sodium and cephalothin in the treatment of serious infections.

Jahre JA, Neu HC, Parry MF, Goldberger MJ.

J Antimicrob Chemother. 1978 Jul;4(B):105-11. No abstract available.

PMID:
357374
49.

The epidemiology of hepatitis B infection in housestaff.

Parry MF, Brown AE, Dobbs LG, Gocke DJ, Neu HC.

Infection. 1978;6(5):204-6.

PMID:
730389
50.

New developments in antimicrobial therapy.

Parry MF.

Del Med J. 1978 Jan;50(1):33-8. No abstract available.

PMID:
631383

Supplemental Content

Loading ...
Support Center